Area of research
Endocrinology, Diabetes and Metabolism · Physiology
Research interest
Research interests include Diabetes Management and Research, Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, and Diet and metabolism studies.
Glycemic variability and iatrogenic hypoglycemia: how to resolve
Should glycaemic variability and times spent in levels 1 and 2 hypoglycaemia be revised downward in type 1 diabetes treated with advanced systems of insulin delivery?
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability
Key indices of glycaemic variability for application in diabetes clinical practice
HbA1c variability and diabetes complications: assessment and implications
Below Which Threshold of Glycemic Variability Is There a Minimal Risk of Hypoglycemia in People with Type 2 Diabetes?
Three Key Indices in Clinical Practice to Better Comprehend the Postprandial and Basal Glucose Contributions in Type 2 Diabetes
Glycaemic variabilities: Key questions in pursuit of clarity
La variabilité glycémique : un facteur de risque singulier à conjuguer au pluriel
Si l'ère des insulines semi-synthétiques et biosynthétiques nous était contée
Review of methods for detecting glycemic disorders
Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses
Number Needed-to-Treat (NNT): Is it a necessary marker of therapeutic efficiency?
Glucocentric risk factors for macrovascular complications in diabetes: Glucose ‘legacy’ and ‘variability’-what we see, know and try to comprehend
Calibration free continuous glucose monitoring (CGM) devices: Weighing up the benefits and limitations
Comment on Echouffo-Tcheugui et al. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. Diabetes Care 2019;42:486–493
The application of simple metrics in the assessment of glycaemic variability
La variabilité glycémique : l’évaluation de son impact passe par des index de mesure et des recommandations simples
Glucose variability: Do we have to revisit the profusion of definitions to avoid confusion?
Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy
Residual dysglycemia when at target HbA1c of 7% (53mmol/mol) in persons with type 2 diabetes
“Mild dysglycemia” in type 2 diabetes: to be neglected or not?
The dawn phenomenon in type 2 diabetes: How to assess it in clinical practice?
Response to Comment on Monnier et al. Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes: Is This of Concern? Diabetes Care 2013;36:4057–4062
Magnitude of the Dawn Phenomenon and Its Impact on the Overall Glucose Exposure in Type 2 Diabetes
Insulin and atherosclerosis: How are they related?
Basal insulin analogs: From pathophysiology to therapy. What we see, know, and try to comprehend?